✦ LIBER ✦

Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy

✍ Scribed by C. Panis; A. C. S. A. Herrera; V. J. Victorino; F. C. Campos; L. F. Freitas; T. De Rossi; A. N. Colado Simão; A. L. Cecchini; R. Cecchini

Book ID: 113062291
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 444 KB
Volume: 133
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-011-1693-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective assessment of chemotherapy-i

Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study)

✍ Katsumasa Kuroi; Kojiro Shimozuma; Yasuo Ohashi; Kazufumi Hisamatsu; Norikazu Ma 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 400 KB

Efficacy and toxicity of vinorelbine wit

Efficacy and toxicity of vinorelbine with doxorubicin/cyclophosphamide combination chemotherapy in a phase I-II study for advanced or recurrent breast cancer patients

✍ Toshiaki Saeki; Shigemitsu Takashima; Masami Ogita; Toshio Tabei; Isamu Adachi; 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 549 KB

Cardiac sequelae of doxorubicin and pacl

Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer

✍ Klein, J L; Rey, P Maroto; Dansey, R D; Karanes, C; Du, W; Abella, E; Cassells, 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 69 KB

PCN45 UK COST-EFFECTIVENESS ANALYSES OF

PCN45 UK COST-EFFECTIVENESS ANALYSES OF DOCETAXEL VERSUS GENERIC PACLITAXEL ONCE WEEKLY AND NAB-PACLITAXEL IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER (MBC) PROGRESSED AFTERANTHRACYCLINE CHEMOTHERAPY

✍ A Benedict; D Cameron; H Corson; S Jones 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Phase II study of dose-dense doxorubicin

Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer

✍ Jesús García-Mata; Andrés García-Palomo; Lourdes Calvo; Ramón Mel; Juan Jesús Cr 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 240 KB

Responses to chemotherapy or chemohormon

Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy: A subset analysis of CALGB study 8081

✍ Carl G. Kardinal; Michael C. Perry; Ann H. Korzun; Mary Alice Rice; Sandra Ginsb 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB 👁 2 views

The Cancer and Leukemia Group B (CALGB) evaluated the response to subsequent chemotherapy or chemohormonal therapy in 46 patients with advanced breast cancer treated previously with adjuvant chemotherapy that had been completed 6 months or more before protocol entry. The results were compared with 3